SEARCH

SEARCH BY CITATION

References

  • 1
    Kahl BC, Duebbers A, Lubritz G et al. Population dynamics of persistent Staphylococcus aureus isolated from the airways of cystic fibrosis patients during a 6-year prospective study. J Clin Microbiol2003; 41: 44244427.
  • 2
    Steinkamp G, Wiedemann B, Rietschel E et al. Prospective evaluation of emerging bacteria in cystic fibrosis. J Cyst Fibros2005; 4: 4148.
  • 3
    Goss CH, Mayer-Hamblett N, Aitken ML et al. Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis. Thorax2004; 59: 955959.
  • 4
    Proctor RA, von Eiff C, Kahl BC et al. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol2006; 4: 295305.
  • 5
    Proctor RA, van Langevelde P, Kristjansson M et al. Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus. Clin Infect Dis1995; 20: 95102.
  • 6
    von Eiff C, Bettin D, Proctor RA et al. Recovery of small colony variants of Staphylococcus aureus following gentamicin bead placement for osteomyelitis. Clin Infect Dis1997; 25: 12501251.
  • 7
    Brakstad OG, Aasbakk K, Maeland JA. Detection of Staphlococcus aureus by polymerase chain reaction amplification of the nuc gene. J Clin Microbiol1992; 30: 16541660.
  • 8
    Lannergard J, von Eiff C, Sander G et al. Identification of the genetic basis for clinical menadione-auxotrophic small-colony variant isolates of Staphylococcus aureus. Antimicrob Agents Chemother2008; 52: 40174022.
  • 9
    Besier S, Smaczny C, von Mallinckrodt C et al. Prevalence and clinical significance of Staphylococcus aureus small-colony variants in cystic fibrosis lung disease. J Clin Microbiol2007; 45: 168172.
  • 10
    Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. CLSI Document M100-S18. Wayne, PA: CLSI, 2008.
  • 11
    Kahl B, Herrmann M, Everding AS et al. Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J Infect Dis1998; 177: 10231029.
  • 12
    Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. CLSI document M100-S20. Wayne, PA: CLSI, 2010.
  • 13
    European Committee on Antimicrobial Susceptibility Testing: Breakpoint tables for interpretation of MICs and zone diameters. Version 1.3, 5 January, 2011.
  • 14
    Goering RV, Winters MA. Rapid method for epidemiological evaluation of gram-positive cocci by field inversion gel electrophoresis. J Clin Microbiol1992; 30: 577580.
  • 15
    Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol1995; 33: 22332239.
  • 16
    Cystic Fibrosis Foundation Patient Registry. Annual Data Report. Bethesda, MD: Cystic Fibrosis Foundation, 2009.
  • 17
    Vergison A, Denis O, Deplano A et al. National survey of molecular epidemiology of Staphylococcus aureus colonization in Belgian cystic fibrosis patients. J Antimicrob Chemother2007; 59: 893899.
  • 18
    Goss CH, Muhlebach MS. Staphylococcus aureus and MRSA in cystic fibrosis. J Cyst Fibros2011; 10: 298306.
  • 19
    Proctor RA, Balwit JM, Vesga O. Variant subpopulations of Staphylococcus aureus as cause of persistent and recurrent infections. Infect Agents Dis1994; 3: 302312.
  • 20
    Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med2003; 168: 918951.
  • 21
    Schneider M, Muhlemann K, Droz S et al. Clinical characteristics associated with isolation of small-colony variants of Staphylococcus aureus and Pseudomonas aeruginosa from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol2008; 46: 18321834.
  • 22
    Hoffman LR, Deziel E, D’Argenio DA et al. Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa. Proc Natl Acad Sci USA2006; 103: 1989019895.
  • 23
    Nguyen HA, Denis O, Vergison A et al. Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: study of antibiotic combinations. Antimicrob Agents Chemother2009; 53: 14431449.
  • 24
    Nguyen HA, Denis O, Vergison A et al. Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype and revertant strains. Antimicrob Agents Chemother2009; 53: 14341442.
  • 25
    Gomez-Gonzalez C, Acosta J, Villa J et al. Clinical and molecular characteristics of infections with CO2-dependent small-colony variants of Staphylococcus aureus. J Clin Microbiol2010; 48: 28782884.
  • 26
    Proctor R. Bacterial energetics and antimicrobial resistance. Drug Resist Updates1998; 1: 227235.
  • 27
    von Eiff C, Peters G, Becker K. The small colony variant (SCV) concept—the role of staphylococcal SCVs in persistent infections. Injury2006; 37 (suppl 2): 2633.
  • 28
    Pan XS, Hamlyn PJ, Talens-Visconti R et al. Small-colony mutants of Staphylococcus aureus allow selection of gyrase-mediated resistance to dual-target fluoroquinolones. Antimicrob Agents Chemother2002; 46: 24982506.
  • 29
    Besier S, Zander J, Kahl BC et al. The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates. Antimicrob Agents Chemother2008; 52: 21832189.
  • 30
    Sener B, Koseoglu O, Ozcelik U et al. Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. Int J Med Microbiol2001; 291: 387393.
  • 31
    Cramer N, Wiehlmann L, Tummler B. Clonal epidemiology of Pseudomonas aeruginosa in cystic fibrosis. Int J Med Microbiol2010; 300: 526533.